Comparative Incidence of Urinary Tract Infections in Diabetic Women Treated with Dapagliflozin Versus Empagliflozin: A Double-Blind Randomized Clinical Trial. (PubMed, Int J Endocrinol Metab) - Sep 21, 2026 - "Monitoring for UTIs is recommended when prescribing SGLT2 inhibitors, particularly empagliflozin. Trial Registration: This trial is registered with the Iranian Registry of Clinical Trials (IRCT20250129064554N1)."
Clinical • Journal • Diabetes • Infectious Disease • Metabolic Disorders • Nephrology • Type 2 Diabetes Mellitus
|
|
Sara Kazem-Nadi; Sara Keshtkari; Vahid Mousavi; Zohre Labbani-Motlagh
|